TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT06498817: ACACIA-HCM: Phase 3 Trial of Aficamten vs Metoprolol in Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)

Sponsor: Cytokinetics, Incorporated · Phase: PHASE3 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 420 pts

Competing Trials Overlap

6 Active Trials

Excess Burn Exposure

$565,728

Rescue Site Savings

+$377,152

Unlock Full NCT06498817 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06498817 Rescue Dossier →